The Assessment of Selected miRNA Profile in Familial Mediterranean Fever

Cigdem Yuce Kahraman1, Mehmet Ertugrul Egin2, Abdulgani Tatar1

  • 1Department of Medical Genetics, Faculty of Medicine, Atatürk University, Erzurum, Turkey.

Insights

Familial Mediterranean fever (FMF) involves altered microRNA (miRNA) expression. This study identified specific upregulated and downregulated miRNAs in FMF patients, suggesting their role in disease pathogenesis and potential as diagnostic markers.

Area of Science:

  • Immunology
  • Genetics
  • Molecular Biology

Background:

  • Familial Mediterranean fever (FMF) is a prevalent autoinflammatory disease.
  • FMF is caused by mutations in the MEFV gene, affecting pyrin protein function in innate immunity and inflammasome regulation.
  • MicroRNAs (miRNAs) are implicated in various diseases, but their role in FMF remains largely unexplored.

Purpose of the Study:

  • To investigate the expression profiles of selected immune-related miRNAs in FMF patients.
  • To identify potential miRNA biomarkers associated with FMF pathogenesis and clinical manifestations.

Main Methods:

  • Genetically diagnosed FMF patients (n=28) and healthy controls (n=28) were recruited.
  • Quantitative reverse transcription PCR (qRT-PCR) was used to determine miRNA expression levels, normalized to SNORD61.
  • Expression profiling of thirteen selected miRNAs was performed.

Main Results:

  • Significant differential expression of several miRNAs was observed in FMF patients compared to controls.
  • Upregulated miRNAs included miR-34a-5p, miR-142-3p, miR-216a-5p, miR-340-5p, miR-429, and miR-582-5p.
  • Downregulated miRNAs included miR-107, miR-569, and miR-1304-5p, with miR-107 showing particular significance in M694V homozygous mutants.

Conclusions:

  • MicroRNAs play a potential role in the pathogenesis of FMF.
  • Specific miRNAs, notably miR-107, may serve as valuable diagnostic or monitoring tools, especially in patients with the M694V mutation associated with amyloidosis.
  • Targeting these miRNAs presents a promising avenue for developing novel FMF therapeutics and diagnostic strategies.

Related Concept Videos